Early test for new weight drug formulations begins

NCT ID NCT07220954

Not yet recruiting Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This early-stage study aims to understand how different injected formulations of an experimental drug called AZD6234 are absorbed into the body. It will involve 21 healthy volunteers who will each try four different versions of the injection. Researchers will measure the drug levels in the blood and check for side effects to determine which formulation works best.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    Ruddington, NG11 6JS, United Kingdom

Conditions

Explore the condition pages connected to this study.